Search
for
Sort by
Research 451–480 of 1000+
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Symptom management in inflammatory bowel disease
- Testosterone Treatment in Women – An Overview
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- Skin health and integrity
- Post-finasteride syndrome – does it really exist?
- The role of aquaporins in polycystic ovary syndrome – A way towards a novel drug target in PCOS
- Role of Non Androgenic Factors in Hair loss and Hair Regrowth
- Alopecia areata incognita in Cronkhite-Canada syndrome
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Skin Diseases in Horses
- The role of androgens in hormone replacement therapy
- Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
- Immunosuppressive therapy in autoimmune disease — A review
- Development and validation of rapid and simultaneous method for determination of 12 hair-growth compounds in adulterated products by UHPLC–MS/MS
- Secondary amenorrhea
- Skin manifestations of endocrine diseases
- Ottawa, Ontario, Canada, February 13–16, 2013
- Oxidative stress and alopecia areata
- Cognitive, emotional, physical, and behavioral stress-related symptoms and coping strategies among university students during the third wave of COVID-19 pandemic
- A Case Report of Male Systemic Lupus Erythematous with Antinuclear Antibodies-Negative: A Challenging Diagnosis
- Phytochemistry and Pharmacological Studies of Glycyrrhiza glabra: A Medicinal Plant Review
- Cutaneous Reactions to Drugs
- RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause
- Hypothyroidism in Dogs
- Menopause
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Debatable Topics in PCOS Patients
- Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatológicas